SMA News Today Community Editor Kevin Schaefer interviews Abby Quinn and Kristen Bathe -- childhood friends who run an inclusive fashion line for people with disabilities. Read all about them here: https://smanewstoday.com/forums/forums/topic/11323/

SMA News Today Community Editor Kevin Schaefer interviews Abby Quinn and Kristen Bathe -- childhood friends who run an inclusive fashion line for people with disabilities. Read all about them here: https://smanewstoday.com/forums/forums/topic/11323/

SMA News & Perspectives - December 10, 2018 by SMA News Today

SMA News & Perspectives - December 10, 2018 by SMA News Today

SMA News Today Community Editor Kevin Schaefer and Forums and Multimedia Director Michael Morale discuss the advantages of taking physical therapy while on active treatment with Spinraza. Kevin discusses his aquatic therapy and Michael discusses his traditional therapy using resistance bands and range of motion and isometric exercises.

SMA News Today Community Editor Kevin Schaefer and Forums and Multimedia Director Michael Morale discuss the advantages of taking physical therapy while on active treatment with Spinraza. Kevin discusses his aquatic therapy and Michael discusses his traditional therapy using resistance bands and range of motion and isometric exercises.

SMA News Today Forums & Multimedia Director Michael Morale discusses the breaking news Zolgensma (AVXS-101) Under Priority FDA Review as Possible Gene Therapy for SMA Type 1.

Read the full report here: https://smanewstoday.com/2018/12/04/zolgensma-avxs-101-under-priority-fda-review-as-possible-gene-therapy-for-sma-type-1/

SMA News Today Forums & Multimedia Director Michael Morale discusses the breaking news Zolgensma (AVXS-101) Under Priority FDA Review as Possible Gene Therapy for SMA Type 1.

Read the full report here: https://smanewstoday.com/2018/12/04/zolgensma-avxs-101-under-priority-fda-review-as-possible-gene-therapy-for-sma-type-1/

SMA News Today Community Editor Kevin Schaefer and Forums Director Michael Morale discuss AveXis' filing for FDA approval of experimental small therapy AVXS-101.

SMA News Today Community Editor Kevin Schaefer and Forums Director Michael Morale discuss AveXis' filing for FDA approval of experimental small therapy AVXS-101.